Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(4.60)
# 996
Out of 5,182 analysts
97
Total ratings
62.79%
Success rate
20.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IPSC Century Therapeutics | Maintains: Buy | $2 → $5 | $2.34 | +113.68% | 1 | Apr 21, 2026 | |
| LEGN Legend Biotech | Reiterates: Buy | $50 | $25.07 | +99.44% | 4 | Apr 21, 2026 | |
| SRPT Sarepta Therapeutics | Reiterates: Sell | $5 | $21.42 | -76.66% | 5 | Apr 16, 2026 | |
| INCY Incyte | Reiterates: Buy | $135 | $96.92 | +39.29% | 6 | Apr 15, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Buy | $40 → $70 | $68.87 | +1.64% | 3 | Apr 13, 2026 | |
| GENB Generate Biomedicines | Initiates: Buy | $16 | $12.12 | +32.01% | 1 | Apr 13, 2026 | |
| ALMS Alumis | Maintains: Buy | $40 → $25 | $24.71 | +1.17% | 4 | Mar 30, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $7 | $2.50 | +180.00% | 1 | Mar 26, 2026 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $110 → $120 | $74.87 | +60.28% | 7 | Mar 25, 2026 | |
| AVTX Avalo Therapeutics | Maintains: Buy | $25 → $40 | $14.66 | +172.85% | 3 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $50 | $27.97 | +78.76% | 3 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $17 | $4.89 | +247.65% | 2 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $30 | $15.21 | +97.24% | 7 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $22 | $21.69 | +1.43% | 3 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $55 | $54.88 | +0.22% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $30 | $25.12 | +19.43% | 8 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $45 | $34.37 | +30.93% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $20 | $14.28 | +40.06% | 3 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $27.74 | +152.34% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $6.53 | +53.14% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.40 | - | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $69.57 | +29.37% | 5 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $20 → $45 | $24.89 | +80.80% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $10.53 | +89.93% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $30 | $6.94 | +332.28% | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $20 | $11.25 | +77.78% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $57.69 | +38.67% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.57 | +40.06% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.53 | +357.52% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $5.37 | -62.76% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.60 | +150.00% | 1 | Aug 11, 2025 |
Century Therapeutics
Apr 21, 2026
Maintains: Buy
Price Target: $2 → $5
Current: $2.34
Upside: +113.68%
Legend Biotech
Apr 21, 2026
Reiterates: Buy
Price Target: $50
Current: $25.07
Upside: +99.44%
Sarepta Therapeutics
Apr 16, 2026
Reiterates: Sell
Price Target: $5
Current: $21.42
Upside: -76.66%
Incyte
Apr 15, 2026
Reiterates: Buy
Price Target: $135
Current: $96.92
Upside: +39.29%
Oruka Therapeutics
Apr 13, 2026
Maintains: Buy
Price Target: $40 → $70
Current: $68.87
Upside: +1.64%
Generate Biomedicines
Apr 13, 2026
Initiates: Buy
Price Target: $16
Current: $12.12
Upside: +32.01%
Alumis
Mar 30, 2026
Maintains: Buy
Price Target: $40 → $25
Current: $24.71
Upside: +1.17%
Palisade Bio
Mar 26, 2026
Initiates: Buy
Price Target: $7
Current: $2.50
Upside: +180.00%
Ionis Pharmaceuticals
Mar 25, 2026
Maintains: Buy
Price Target: $110 → $120
Current: $74.87
Upside: +60.28%
Avalo Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $25 → $40
Current: $14.66
Upside: +172.85%
Mar 18, 2026
Maintains: Buy
Price Target: $65 → $50
Current: $27.97
Upside: +78.76%
Mar 16, 2026
Maintains: Buy
Price Target: $10 → $17
Current: $4.89
Upside: +247.65%
Mar 3, 2026
Maintains: Buy
Price Target: $25 → $30
Current: $15.21
Upside: +97.24%
Mar 2, 2026
Maintains: Buy
Price Target: $25 → $22
Current: $21.69
Upside: +1.43%
Mar 2, 2026
Reiterates: Neutral
Price Target: $55
Current: $54.88
Upside: +0.22%
Feb 24, 2026
Maintains: Buy
Price Target: $40 → $30
Current: $25.12
Upside: +19.43%
Feb 17, 2026
Maintains: Buy
Price Target: $30 → $45
Current: $34.37
Upside: +30.93%
Jan 29, 2026
Upgrades: Buy
Price Target: $20
Current: $14.28
Upside: +40.06%
Jan 13, 2026
Reiterates: Buy
Price Target: $70
Current: $27.74
Upside: +152.34%
Jan 13, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $6.53
Upside: +53.14%
Jan 7, 2026
Downgrades: Neutral
Price Target: n/a
Current: $8.40
Upside: -
Dec 19, 2025
Reiterates: Buy
Price Target: $90
Current: $69.57
Upside: +29.37%
Dec 9, 2025
Upgrades: Buy
Price Target: $20 → $45
Current: $24.89
Upside: +80.80%
Nov 24, 2025
Initiates: Buy
Price Target: $20
Current: $10.53
Upside: +89.93%
Nov 19, 2025
Maintains: Buy
Price Target: $40 → $30
Current: $6.94
Upside: +332.28%
Oct 27, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $11.25
Upside: +77.78%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $57.69
Upside: +38.67%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $3.57
Upside: +40.06%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.53
Upside: +357.52%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $5.37
Upside: -62.76%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.60
Upside: +150.00%